The Problem With How Diabetes Is Tested in India
Most people with diabetes in India are under-tested. They get an HbA1c every 3–6 months and a blood sugar occasionally. That's it. Meanwhile, kidney damage builds silently for years. Nerve damage progresses undetected. The back of the eye deteriorates without a single fundus examination ever being done.
At the same time, some patients are over-tested — paying for scans and investigations that add no clinical value while missing the basic annual checks that actually matter.
This page explains the complete diabetes testing framework — from the tests used to diagnose diabetes and pre-diabetes, to the monitoring done at every visit, to the annual complication screening that detects damage before it becomes irreversible. This is the exact protocol Dr. Bhansali's team follows at Gini Hospital.
The Diabetes Spectrum — From Normal to Complications
The Most Important Stage Is the One You Can Still Reverse
Pre-diabetes is the last window where diabetes can be completely prevented. At Gini, we aggressively treat pre-diabetes — not just monitor it. Weight management, structured exercise, dietary intervention, and where indicated metformin or GLP-1 therapy can reverse pre-diabetes in the majority of patients if the intervention is started early enough.
Tests Used to Diagnose Diabetes and Pre-Diabetes
Diabetes is diagnosed using one of three tests — or a combination. No single symptom is enough. No single glucose reading is enough (except in specific circumstances). Here is what each test means and when it is used.
HbA1c (Glycated Haemoglobin) →
| Result | Category | Meaning |
|---|---|---|
| Below 5.7% | Normal | No diabetes |
| 5.7% – 6.4% | Pre-diabetes | Elevated risk — intervene now |
| 6.5% and above | Diabetes | Diagnosis confirmed (confirm with second test if no symptoms) |
| 7.0% or below | Treatment target | Goal for most patients on treatment |
| 8.0% or above | Poor control | Significantly elevated complication risk |
| 10%+ | Very poor control | Urgent treatment intensification needed |
Why Gini uses this: HbA1c is the most reliable diagnostic test because it is not affected by what you ate that morning, time of day, or stress. Dr. Bhansali uses HbA1c as the primary monitoring tool for every patient.
Indian-specific note: HbA1c can be falsely low in patients with iron deficiency anaemia, haemolytic anaemia, or haemoglobin variants — all common in India. Dr. Bhansali checks for these before relying solely on HbA1c. In these patients, Fructosamine or Glycated Albumin is used instead.
Limitation: Does not detect rapid glucose swings — a patient with wide swings between very high and very low may have a "normal" HbA1c that masks poor control. Gini uses CGM alongside HbA1c in these patients.
Fasting Blood Glucose (FBG) →
| Result | Category |
|---|---|
| 70–99 mg/dL | Normal |
| 100–125 mg/dL | Pre-diabetes (Impaired Fasting Glucose) |
| 126 mg/dL and above | Diabetes (confirm with repeat test) |
A single elevated fasting glucose is not enough to diagnose diabetes — it must be confirmed with a repeat test on a different day, or confirmed by HbA1c.
Post-Prandial Glucose (PPBG)
| Result | Category |
|---|---|
| Below 140 mg/dL | Normal |
| 140–199 mg/dL | Pre-diabetes (Impaired Glucose Tolerance) |
| 200 mg/dL and above | Diabetes |
Why this matters: Post-prandial glucose detects impaired glucose tolerance — a form of pre-diabetes that fasting glucose can miss. Some patients have normal fasting glucose but abnormal post-meal glucose. Testing both gives the complete picture.
Oral Glucose Tolerance Test (GTT / OGTT)
The most sensitive test for diagnosing pre-diabetes and gestational diabetes. Fasting blood draw → drink 75g glucose solution → blood draws at 1 hour and 2 hours. Takes 2.5 hours total. Sit quietly during the test — do not eat, drink (except water), or exercise.
Who needs this:
- Anyone with borderline HbA1c or fasting glucose who needs clarity
- All pregnant women (gestational diabetes screening at 24–28 weeks)
- Anyone with PCOS (very high risk of glucose intolerance)
- Family history of diabetes with normal routine tests
| 2-Hour Value | Category |
|---|---|
| Below 140 mg/dL | Normal |
| 140–199 mg/dL | Impaired Glucose Tolerance (Pre-diabetes) |
| 200 mg/dL and above | Diabetes |
Gestational Diabetes (GDM): Different thresholds apply. Gini follows DIPSI criteria (standard for India): fasting below 92, 1-hour below 180, 2-hour below 153 mg/dL.
Fasting Insulin and HOMA-IR →
Measures how much insulin your pancreas is producing (Fasting Insulin) and how insulin resistant you are (HOMA-IR = calculated from glucose + insulin). Same blood draw as fasting glucose — no extra needle needed.
Why most clinics don't do this — and why they should
A patient can have a normal fasting glucose but a fasting insulin of 25 µIU/mL — meaning their pancreas is working 5× harder than normal just to keep glucose normal. This is severe insulin resistance, and it will eventually exhaust the pancreas and produce diabetes. Detecting it now allows treatment before diabetes develops.
| Test | Normal | Insulin Resistance |
|---|---|---|
| Fasting Insulin | 2–10 µIU/mL | Above 15 µIU/mL |
| HOMA-IR | Below 1.0 | Above 2.5 (significant) |
Dr. Bhansali's approach: Tests fasting insulin and HOMA-IR in all pre-diabetic patients and in PCOS — because these patients need metformin or GLP-1 therapy based on insulin resistance severity, not just glucose levels.
C-Peptide →
Measures true insulin production by the pancreas — not affected by injected insulin. Distinguishes Type 1 from Type 2 and assesses remaining beta cell function.
When it's used:
- Newly diagnosed younger patients — is this Type 1 or Type 2?
- Long-standing Type 2 — does the pancreas still produce any insulin?
- Determining if insulin therapy is truly needed
- Assessing response to stem cell or beta cell preservation therapy
| C-Peptide | Interpretation |
|---|---|
| Below 0.2 nmol/L | Very little beta cell function — likely Type 1 or advanced Type 2 |
| 0.5–2.0 nmol/L | Adequate insulin production |
| Above 3.0 nmol/L | Excess production — severe insulin resistance |
Fructosamine (Alternative to HbA1c)
Measures average blood sugar over the past 2–3 weeks (shorter window than HbA1c). Used when HbA1c is unreliable — anaemia, haemoglobin variants, kidney disease, recent blood transfusion. Gini price: on request.
Which Diabetes Test Should You Get?
- Health check, no symptoms: HbA1c + Fasting Glucose together (catches both types of pre-diabetes)
- Symptoms of diabetes (thirst, urination, weight loss): HbA1c + Fasting Glucose urgently — same day if possible
- Pregnant: GTT at 24–28 weeks regardless of risk
- PCOS or family history: HbA1c + Fasting Glucose + Fasting Insulin + HOMA-IR
- Previously normal but now borderline: GTT for definitive answer
- Anaemia or haemoglobin variant: Fructosamine instead of HbA1c
The Gini Monitoring Framework
Once diabetes is diagnosed, the question shifts from "Do I have it?" to "How well is it controlled?" and "Has it damaged anything yet?" At Gini, every patient follows a structured monitoring protocol designed by Dr. Bhansali based on PGIMER's research programme and international diabetes guidelines.
⏱ Every Visit
- HbA1c — every 3 months if uncontrolled; every 6 months if controlled. Tracking the trend is what matters.
- Blood Pressure — target below 130/80 mmHg in diabetics. Measured every visit without exception.
- Weight and BMI — every 1kg of weight loss reduces HbA1c by ~0.1%.
- Brief foot exam — 30-second visual check that saves limbs.
- Medication review — side effects, adherence, dose adjustment.
- Injection site check — for insulin users; lipohypertrophy causes erratic absorption.
📅 Every 3 Months
- HbA1c (if not yet at target)
- BP & Weight trend review
- Fasting Lipid Profile if on statin or abnormal
- Kidney function if on ACE inhibitors or SGLT2 inhibitors
- CGM download review — for patients using continuous glucose monitors. Time-in-range, not just HbA1c.
- Medication titration — additions, simplifications based on trends.
📊 Every Year — Complications Screen
- HbA1c if controlled (3-monthly otherwise)
- Complete Lipid Profile — target LDL <100 (<70 if cardiac history)
- Urine ACR + Serum Creatinine — full kidney screen
- VPT — neuropathy screen
- ABI — vascular screen
- Fundus Examination — retinopathy screen
- ECG — cardiac electrical baseline
- TSH — thyroid (3× more common in diabetics)
- Vitamin B12 — for all metformin users
- Vitamin D — 80%+ of new diabetics deficient
- CBC, Uric Acid — baseline
- ApoB + hsCRP — every 1–2 years
The Annual Complications Screen — In Detail
Kidney Function — Two Tests, Both Essential
Urine Albumin/Creatinine Ratio (ACR) — ₹500. The most sensitive early kidney test. Detects albumin leaking into urine 5–10 years before creatinine rises.
Serum Creatinine + eGFR — ₹100. Measures actual kidney filtration rate. By the time creatinine is elevated, 40–50% of kidney function is already lost. This is why urine ACR is tested first.
| Test | Normal | Abnormal |
|---|---|---|
| Urine ACR | Below 30 mg/g | 30–300 = microalbuminuria; >300 = overt nephropathy |
| eGFR | Above 90 mL/min | 60–90 mild; 30–60 significant; <30 pre-dialysis |
VPT — Vibration Perception Threshold (Neuropathy Screen)
A neurothesiometer measures the minimum vibration a patient can feel at the big toe. Detects diabetic peripheral neuropathy — nerve damage in the feet. 15 minutes, completely painless.
Why it matters: Neuropathy is the leading cause of diabetic foot ulcers and amputation — and it's preventable with better glucose control if caught early.
ABI — Ankle Brachial Index (Peripheral Vascular Screen)
Blood pressure cuffs on both arms and both ankles. The ratio reveals whether blood flow to the feet is reduced — peripheral arterial disease (PAD). No needles, 20 minutes.
Why it matters: PAD + diabetic neuropathy = the combination that causes most amputations. Detecting PAD early enables vascular intervention that saves limbs.
Fundus Examination (Diabetic Retinopathy Screen)
Examination of the back of the eye (retina) by an ophthalmologist — with pupil dilation or using a non-mydriatic fundus camera. Gini price: ₹500 (non-mydriatic fundus photo).
Stages of diabetic retinopathy:
- No retinopathy: Repeat annually
- Mild NPDR: Optimize glucose and BP, repeat in 6–12 months
- Moderate NPDR: Refer to ophthalmologist
- Severe NPDR / PDR: Urgent referral — laser/injection therapy
- Macular oedema: Urgent treatment
The eye does not warn you. Diabetic retinopathy is the leading cause of preventable blindness in working-age adults in India. It has no symptoms until vision is already damaged. Annual screening catches it before this point.
Cardiac Assessment (Annual)
ECG detects silent myocardial ischaemia (heart attacks without chest pain — common in diabetics due to neuropathy affecting cardiac nerves). 2D Echo every 2–3 years (annually with hypertension or symptoms). TMT for diabetics with cardiac symptoms or planning vigorous exercise.
Vitamin B12 — Tested in ALL Metformin Patients
Vitamin B12 — ₹600. Metformin depletes B12 in 30% of long-term users. B12 deficiency causes peripheral neuropathy — which mimics and worsens diabetic neuropathy. Annual B12 testing is standard protocol at Gini for every patient on metformin.
Most clinics don't test B12 in metformin patients. Yet two well-established facts: metformin depletes B12, and B12 deficiency causes neuropathy. This is treatable for ₹600 a year. At Gini it is non-negotiable.
Other Annual Tests
- TSH — ₹200. Thyroid disease 3× more common in diabetics. Annual in Type 2; every 6 months in Type 1 (high autoimmune risk).
- Vitamin D — ₹800. Deficiency worsens insulin resistance. 80%+ of new diabetic patients deficient at Gini.
- Uric Acid — ₹120. Hyperuricaemia associated with metabolic syndrome and cardiovascular risk.
- CBC — ₹350. Anaemia screening — extremely common in Indian diabetics, especially women.
- ApoB — ₹800 + hsCRP — ₹700 every 1–2 years. Complete cardiovascular risk beyond standard lipid profile.
Body Composition — Beyond Weight and BMI
BMI is an imperfect tool for Indians. Indians develop metabolic complications at much lower BMI than Western populations — the WHO now recommends lower thresholds for Asians.
| Category | Western (general) | Asian (Indian) |
|---|---|---|
| Normal | 18.5–24.9 | 18.5–22.9 |
| Overweight | 25.0–29.9 | 23.0–27.4 |
| Obese | 30.0+ | 27.5+ |
The "Thin Fat" Indian (TOFI)
Indians frequently have "normal" BMI but high body fat — TOFI (Thin Outside, Fat Inside) — visceral fat driving insulin resistance without obvious obesity. This is why body fat percentage and waist circumference matter more than BMI alone.
Waist circumference thresholds (Indian): Men above 90cm, women above 80cm = abdominal obesity (visceral fat accumulation — highest metabolic risk).
What Gini measures at each visit: Weight, BMI (calculated), waist circumference (annually), body fat percentage on request (bioimpedance).
The Monitoring Schedule at a Glance
| Test | Every Visit | 3 Monthly | 6 Monthly | Annually | Every 2 Yrs |
|---|---|---|---|---|---|
| HbA1c | ✓ If uncontrolled | ✓ If controlled | |||
| Blood Pressure | ✓ | ||||
| Weight / BMI | ✓ | ||||
| Brief Foot Check | ✓ | ||||
| Fasting Glucose | ✓ | ||||
| Lipid Profile | ✓ | ||||
| Urine ACR (Kidney) | ✓ | ||||
| Creatinine + eGFR | ✓ | ||||
| VPT (Neuropathy) | ✓ | ||||
| ABI (Vascular) | ✓ | ||||
| Fundus Exam | ✓ | ||||
| ECG | ✓ | ||||
| 2D Echo | ✓ | ||||
| TSH (Thyroid) | ✓ | ||||
| Vitamin B12 | ✓ | ||||
| Vitamin D | ✓ | ||||
| CBC | ✓ | ||||
| ApoB + hsCRP | ✓ | ||||
| DEXA Scan | ✓ |
The Gini Advantage — What Most Clinics Miss
All complication screening done in-house
VPT, ABI, fundus, ECG, Echo, all blood tests — done at Gini's NABH-accredited lab. No referrals to multiple centres. One visit, complete screen.
Monthly external quality validation
Every month, Gini's lab samples are tested blind against international reference standards. Any drift is corrected before it affects patient reports. More on lab quality →
Dr. Bhansali reviews all abnormal results
If your HbA1c rises, your urine ACR crosses 30, your VPT is borderline — these are not just numbers in a report. Dr. Bhansali's team is notified and acts before your next visit.
B12 in all metformin patients — standard
Metformin depletes B12. B12 deficiency causes nerve damage. These two facts are well known. Yet most clinics never test B12 in metformin patients. At Gini it is annual protocol.
Indian-specific interpretation
Our ranges, thresholds, and risk calculations are calibrated to Indian patients — not Western populations. ABI, HOMA-IR, BMI, lipids — everything interpreted in Indian clinical context.
CGM integration
For patients with highly variable glucose or who use continuous glucose monitors — Dr. Bhansali downloads and reviews CGM data at every visit. Time-in-range, not just HbA1c, guides treatment decisions.
How to Prevent Diabetes
Pre-diabetes is reversible. Type 2 diabetes can be prevented or significantly delayed in 58–71% of high-risk individuals with the right interventions — this is one of the most robust findings in diabetes medicine.
1. Weight Loss (Most Powerful)
Every 1kg of weight loss in a pre-diabetic reduces diabetes risk by approximately 16%. Losing 5–7% of body weight (4–5kg for a 70kg person) reduces risk by over 50%. This is not about reaching ideal weight — even modest sustained weight loss is powerful.
Mechanism: less visceral fat → less inflammation → improved insulin sensitivity → pancreas needs to work less hard.
2. Resistance Training (Underused, Highly Effective)
Most people think cardio is the diabetes prevention exercise. The evidence says resistance training (weights, resistance bands, bodyweight exercises) improves insulin sensitivity more durably. Aim for 3 sessions per week of 30–40 minutes. Muscle is the largest glucose disposal organ in the body — more muscle = better glucose control.
3. Dietary Change (Specific, Not Generic)
What the evidence actually supports:
- Reduce refined carbohydrates (maida, white rice, white bread, packaged snacks, sugary beverages)
- Increase protein at every meal (reduces glucose spikes, increases satiety)
- Don't fear fat — replacing refined carbohydrates with healthy fats (ghee, nuts, olive oil, avocado) reduces insulin resistance
- Fibre — dal, vegetables, whole grains slow glucose absorption
- Meal timing — eating within a 10–12 hour window improves insulin sensitivity
What doesn't work: skipping meals, juice fasting, extreme low-calorie diets without medical supervision, eliminating entire food groups without replacements.
4. Sleep (The Forgotten Metabolic Lever)
Less than 6 hours of sleep per night increases diabetes risk by 44%. Poor sleep raises cortisol (raises blood sugar), reduces GLP-1 (the body's own appetite and glucose regulator), and causes carbohydrate cravings. Untreated obstructive sleep apnea causes significant insulin resistance — treating it with CPAP improves HbA1c without any medication change.
5. Stress Management
Chronic psychological stress raises cortisol chronically. Cortisol raises blood sugar. This is a biochemical reality, not a lifestyle platitude. Stress-related HbA1c elevation is real and documented. Interventions: adequate sleep, exercise, social support, mindfulness — whatever the patient will actually do.
6. Metformin (For High-Risk Pre-Diabetics)
The Diabetes Prevention Program showed metformin reduces diabetes progression in high-risk pre-diabetics by 31% — less than lifestyle change (58%) but significant for those who cannot achieve lifestyle targets. Dr. Bhansali prescribes metformin in pre-diabetics with HOMA-IR above 2.5, BMI above 27, or HbA1c above 6.0%, in combination with lifestyle intervention.
7. GLP-1 Therapy (Emerging, Powerful)
In patients with severe insulin resistance, obesity, and pre-diabetes — GLP-1 agonists (Mounjaro, Ozempic, Wegovy) reduce progression to diabetes dramatically (Tirzepatide SURMOUNT-1: 94% risk reduction in pre-diabetics). Dr. Bhansali uses GLP-1 in pre-diabetics with significant obesity and high insulin resistance after discussion of cost and commitment. Pre-GLP-1 baseline panel →
Am I at Risk? — 90-Second Self-Assessment
Tick all that apply. Your risk score appears below.
Protecting Yourself Once You Have Diabetes
Diabetes is not a death sentence. It is a manageable condition. With the right monitoring and control, most people with diabetes live long, full lives without significant complications. Here is what protecting yourself looks like, organ by organ.
🍳 Protecting Your Kidneys
- Keep HbA1c below 7.0% — the single most important kidney-protective intervention
- Keep blood pressure below 130/80 — equally important
- Annual urine ACR — catch the earliest sign of leak
- ACE inhibitor or ARB if ACR above 30 — these specifically slow kidney damage
- Avoid nephrotoxic medications: NSAIDs (ibuprofen, diclofenac), contrast dye without adequate hydration — discuss with Dr. Bhansali before any new medication
👁️ Protecting Your Eyes
- Annual fundus examination — non-negotiable
- HbA1c control — every 1% reduction in HbA1c reduces retinopathy progression by 37%
- Blood pressure control
- Stop smoking if applicable
- Early laser treatment when recommended — significantly reduces vision loss risk
⚡ Protecting Your Nerves
- Annual VPT testing
- HbA1c control — neuropathy progression slows dramatically with better control
- Vitamin B12 — supplement if low, especially on metformin
- Foot care daily: wash and dry between toes, inspect daily, appropriate footwear
- Avoid barefoot walking — even at home
- Capsaicin cream, duloxetine, pregabalin for established painful neuropathy
🦴 Protecting Your Feet
- Annual ABI to screen for vascular disease
- Regular podiatry — nail trimming, callus removal
- Diabetic footwear — properly fitted, no tight areas, cushioned sole
- Never ignore any foot wound — seek care within 24 hours. Diabetic foot warning signs →
- Dr. Beant Sidhu (diabetic foot specialist) available at Gini for any foot concern
❤️ Protecting Your Heart
- Statin therapy for most diabetics (regardless of cholesterol level — statins reduce cardiovascular events by 25–35% in diabetics)
- Blood pressure below 130/80
- Aspirin in high-risk patients (discuss with Dr. Bhansali — not everyone needs it)
- Annual ECG, 2-yearly Echo
- SGLT2 inhibitors and GLP-1 agonists have proven cardiac protection — Dr. Bhansali considers these in patients with cardiovascular risk
🧠 Protecting Your Mental Health
Depression is 2–3× more common in people with diabetes. Diabetes causes real stress — monitoring, medications, fear of complications. This is recognised at Gini. If you are struggling, tell us. We treat the whole patient.